Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease

NACompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

July 30, 2024

Study Completion Date

July 30, 2024

Conditions
Diabetic Kidney Disease (DKD)
Interventions
DIAGNOSTIC_TEST

Tests of the expression of CXCL3 in various tissues

1.The expression of CXCL3 in peripheral blood PBMC was detected by RT-qPCR. 2.The levels of CXCL3 in serum and urine were detected by Elisa method. 3.Clinical data collection includes the patient \'s name, gender, weight, height, biochemical indicators, urine test indicators, renal biopsy data, etc. 4.The expression of CXCL3 in renal tissue was determined by immunohistochemistry.

Trial Locations (1)

130021

The First Hospital of Jilin University, Changchun

All Listed Sponsors
lead

The First Hospital of Jilin University

OTHER

NCT06639529 - Preliminary Study of CXCL3 As a Biomarker of Diabetic Kidney Disease | Biotech Hunter | Biotech Hunter